These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18315767)

  • 1. LabCorp v. Metabolite Laboratories: The Supreme Court listens, but declines to speak.
    Klein RD; Mahoney MJ
    J Law Med Ethics; 2008; 36(1):141-9, 4. PubMed ID: 18315767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supreme Court rules against gene patents.
    Kuehn BM
    JAMA; 2013 Jul; 310(4):357-9. PubMed ID: 23917268
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene patenting--the Supreme Court finally speaks.
    Kesselheim AS; Cook-Deegan RM; Winickoff DE; Mello MM
    N Engl J Med; 2013 Aug; 369(9):869-75. PubMed ID: 23841703
    [No Abstract]   [Full Text] [Related]  

  • 5. U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes.
    Levenson D
    Am J Med Genet A; 2013 Sep; 161A(9):ix-x. PubMed ID: 23946205
    [No Abstract]   [Full Text] [Related]  

  • 6. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
    Kumamoto A; Schmid CL
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequenom, the U.S. Supreme Court, and Personalized Medicine.
    Kodroff CA
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):49-52. PubMed ID: 27267566
    [No Abstract]   [Full Text] [Related]  

  • 8. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.
    Dyer C
    BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequenom v. Ariosa - The Death of a Genetic Testing Patent.
    Cook-Deegan R; Chandrasekharan S
    N Engl J Med; 2016 Dec; 375(25):2418-2419. PubMed ID: 28002697
    [No Abstract]   [Full Text] [Related]  

  • 10. Continental drift? Do European clinical genetic testing laboratories have a patent problem?
    Liddicoat J; Liddell K; McCarthy AH; Hogarth S; Aboy M; Nicol D; Patton S; Hopkins MM
    Eur J Hum Genet; 2019 Jul; 27(7):997-1007. PubMed ID: 30846855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2015 Feb; 31(2):209-13. PubMed ID: 25744269
    [No Abstract]   [Full Text] [Related]  

  • 12. Supreme Court ruling broadens BRCA testing options.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
    [No Abstract]   [Full Text] [Related]  

  • 13. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US personalized-medicine industry takes hit from Supreme Court.
    Ledford H
    Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042
    [No Abstract]   [Full Text] [Related]  

  • 15. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?
    Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS
    Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical-process patents.
    Klein RD
    N Engl J Med; 2007 Feb; 356(7):753-4. PubMed ID: 17301313
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 18. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
    Bouchard RA
    Health Law J; 2007; 15():247-94. PubMed ID: 19702185
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic method patents and harms to follow-on innovation.
    Harv Law Rev; 2013 Mar; 126(5):1370-91. PubMed ID: 25330558
    [No Abstract]   [Full Text] [Related]  

  • 20. From Bilski back to Benson: preemption, inventing around, and the case of genetic diagnostics.
    Dreyfuss R; Evans JP
    Stanford Law Rev; 2011 Jun; 63(6):1349-76. PubMed ID: 21774194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.